HLA and cancer: from research to clinical impact.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Immunology today (Amsterdam. Regular ed.)

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0167-5699(98)01349-8PMID 9864942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses.

  1998cited by this paper
• Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression.

  1998cited by this paper
• In vivo and in vitro generation of a new altered HLA phenotype in melanoma‐tumour‐cell variants expressing a single HLA‐class‐I allele

  1998cited by this paper
• Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

  1997cited by this paper
• Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.

  1997cited by this paper
• Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor.

  1997cited by this paper
• The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells

  1997cited by this paper
• Viral decoy vetoes killer cell

  1997cited by this paper
• Receptors for HLA class-I molecules in human natural killer cells.

  1996cited by this paper
• Mechanisms of loss of HLA class I expression on colorectal tumor cells.

  1996cited by this paper
• HLA class I antigens in human tumors.

  1995cited by this paper
• Tumor antigens recognized by T lymphocytes.

  1994cited by this paper
• MHC loss in colorectal tumours: evidence for immunoselection?

  1992cited by this paper
• The biological consequences of altered MHC expression on tumours.

  1987cited by this paper
• Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines.

  1976cited by this paper
• Further evidence for derepression of H–2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines

  1976cited by this paper

• Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell antitumor immunity

  2024cites this paper
• Impaired intratumoral dendritic cell function and potential predictive value of dendritic cell markers for metastasis in malignant salivary gland tumors

  2023cites this paper
• Applications of trimerbodies in cancer immunotherapy.

  2022cites this paper
• Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus

  2022cites this paper
• EBV protection‐ and susceptibility‐related HLA alleles and EBV status in the Chinese population: A single‐center study

  2022cites this paper
• Immunogenetics of Cancer

  2020cites this paper
• Estudio de factores genéticos, inmunológicos y del microambiente medular en la progresión del síndrome mielodisplásico

  2020cites this paper
• Downregulation of human leukocyte antigen Class I expression: An independent prognostic factor in colorectal cancer

  2020cites this paper
• Epstein-Barr Virus and the Human Leukocyte Antigen Complex

  2019cites this paper
• MHC Class-I Loss and Cancer Immune Escape

  2019cites this paper
• HLA Class-I Expression and Cancer Immunotherapy.

  2019cites this paper
• Integrated genome sizing (IGS) approach for the parallelization of whole genome analysis

  2018cites this paper
• Graph-guided assembly for novel HLA allele discovery

  2017cites this paper
• Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.

  2016cites this paper
• Cancer vaccines

  2015cites this paper
• Caractérisation de l'activité fonctionnelle et métabolique des cellules NK en situation de stress nutritionnels : approche expérimentale in vitro et in vivo

  2012cites this paper
• Implicaciones de las moléculas del complejo mayor de histocompatibilidad y de las células T en la generación de variantes metastásicas en un modelo tumoral murino

  2011cites this paper
• Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.

  2009cites this paper
• Clinical significance of HLA class I heavy chain expression in patients with gastric cancer

  2008cites this paper
• HLA-B gene participates in the NF-kappaB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2.

  2008cites this paper
• Introduction to Cytokines as Targets for Immunomodulation

  2007cites this paper
• The low rate of HLA class I molecules on the human embryonic stem cell line HS293 is associated with the APM components' expression level

  2007cites this paper
• The Double Role of the Endoplasmic Reticulum Chaperone Tapasin in Peptide Optimization of HLA Class I Molecules

  2007cites this paper
• A theory of multi-site vaccination for cancer

  2006cites this paper
• Differential proteome analysis of colon carcinoma cell line SW480 after reconstitution of the tumour suppressor Smad4

  2006cites this paper
• Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma.

  2005cites this paper
• Involvement of the chaperone tapasin in HLA‐B44 allelic losses in colorectal tumors

  2005cites this paper
• IMPLICACIONES DE LAS MOLÉCULAS DEL COMPLEJO MAYOR DE HISTOCOMPATIBILIDAD Y DE LAS CÉLULAS T EN LA GENERACIÓN DE VARIANTES METASTÁSICAS EN UN

  2005cites this paper
• Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals

  2005cites this paper
• Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma.

  2005cites this paper
• The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors: Evaluation of Four Different scFvs and Antigens

  2005cites this paper
• A CD80-transfected human breast cancer cell variant induces HER-2/neu–specific T cells in HLA-A*02–matched situations in vitro as well as in vivo

  2005cites this paper
• Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.

  2004cites this paper
• A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity

  2004cites this paper
• Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient

  2004cites this paper
• A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile

  2004cites this paper
• The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.

  2003cites this paper
• CHAPTER 61 – Assays for cytokines

  2003cites this paper
• Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells.

  2003cites this paper
• MHC class I antigens, immune surveillance, and tumor immune escape

  2003cites this paper
• Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition?

  2003cites this paper
• Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases.

  2002cites this paper
• HLA class I expression in primary hepatocellular carcinoma.

  2002cites this paper
• Allogeneic MHC class I ligands and their role in positive and negative regulation of human cytotoxic effector cells.

  2002cites this paper
• Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon.

  2002cites this paper
• Immunodominance and tumor escape.

  2002cites this paper
• HLA-G in Melanoma: A New Strategy to Escape from Immunosurveillance?

  2002cites this paper
• Analysis of HLA expression in human tumor tissues

  2002cites this paper
• Lösliche Serumfaktoren als prognostische Marker des Melanoms: sHLA, sFas und IL-8

  2002cites this paper
• MHC antigens and tumor escape from immune surveillance.

  2001cites this paper
• Cancer vaccines.

  2001cites this paper
• Investigation of HLA class I downregulation in breast cancer by RT-PCR.

  2001cites this paper
• Immunoselection by T lymphocytes generates repeated MHC class I‐deficient metastatic tumor variants

  2001cites this paper
• Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments.

  2001cites this paper
• Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.

  2001cites this paper
• Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2.

  2001cites this paper
• Strategies for immunotherapy of cancer.

  2000cites this paper
• Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

  2000cites this paper
• The HLA crossroad in tumor immunology.

  2000cites this paper
• Dendritische Zellen und andere neue Vakzinationsstrategien zur Therapie des Melanoms und anderer Tumoren

  2000cites this paper
• High frequency of altered HLA class I phenotypes in laryngeal carcinomas.

  2000cites this paper
• 免疫研究の新たな展開のためのヒト主要組織適合抗原複合体(HLA)(3)

  2000cites this paper
• β2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors

  2000cites this paper
• Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology

  2000cites this paper
• Tumor Antigen Pulsed Dendritic Cells Enhance the Cytolytic Activity of Tumor Infiltrating Lymphocytes in Human Hepatocellular Cancer

  2000cites this paper
• „Immune escape”-Mechanismen von humanen Tumoren

  1999cites this paper
• Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.

  1999cites this paper
• Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells.

  1999cites this paper
• The biological consequences of altered MHC class I expression in tumours.

  1999cites this paper
• Selective MHC expression in tumours modulates adaptive and innate antitumour responses

  1999cites this paper
• HLA-G protein expression is not induced during malignant transformation.

  1999cites this paper
• Carcinoma Recognized by of a Human Gastric Signet Ring Cell Identification of Natural Antigenic Peptides

  1999cites this paper
• Identification of natural antigenic peptides of a human gastric signet ring cell carcinoma recognized by HLA-A31-restricted cytotoxic T lymphocytes.

  1999cites this paper
• Generation of Anti-p 53 Cytotoxic T Lymphocytes from Human Peripheral Blood Using Autologous Dendritic Cells 1

  1999cites this paper
• Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

  1999cites this paper
• HLA Class I

  1998cites this paper